<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01168375</url>
  </required_header>
  <id_info>
    <org_study_id>8742</org_study_id>
    <nct_id>NCT01168375</nct_id>
  </id_info>
  <brief_title>The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy</brief_title>
  <official_title>The Role of Umbilical Cord Serum Therapy on Improvement of Corneal Epithelial Defect Following Diabetic Vitrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ophthalmic Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      80 diabetic patients underwent vitrectomy and had no history of Eye herpes infection,
      Refractive surgery, Autoimmune disease, Immune deficiency will be randomized into two groups
      (double blind)to evaluate the role of umbilical cord serum therapy on improvement of corneal
      epithelial defect following diabetic vitrectomy. Both groups will take the conventional
      medication including Chloramphenicol, Betamethasone, Cycloplegic eye drops besides the case
      group will take umbilical cord serum eye drop in the eye operated. After surgery the corneal
      epithelial defect will be measured by slit lamp.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>measurement of corneal epithelial defect</measure>
    <description>measurement of corneal epithelial defect in days 3,5,7,12 by slit lamp</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Corneal Epithelial Defect</condition>
  <arm_group>
    <arm_group_label>conventional therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>chloramphenicol and betamethasone eye drops every 6 hours, cycloplegic (homatropine) eye drop every 8 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional therapy plus umbilical cord serum eye drop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>conventional therapy plus umbilical cord serum eye drop</intervention_name>
    <description>chloramphenicol and betamethasone eye drops every 6 hours, cycloplegic (homatropine) eye drop every 8 hours plus umbilical cord serum eye drop 20% every 4 hours</description>
    <arm_group_label>conventional therapy plus umbilical cord serum eye drop</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>conventional therapy</intervention_name>
    <description>chloramphenicol and betamethasone eye drops every 6 hours, cycloplegic (homatropine) eye drop every 8 hours</description>
    <arm_group_label>conventional therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetic patients with corneal epithelial defect following diabetic vitrectomy at
             labbafinejad Hospital

        Exclusion Criteria:

          -  Any history of Eye herpes infection, Refractive surgery, Autoimmune disease, Immune
             deficiency

          -  Patients with one eye

          -  Use of any eye drops except Chloramphenicol, Betamethasone, Cycloplegic and contact
             lens for corneal epithelial defect
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ophthalmic Research Center</name>
      <address>
        <city>Tehran</city>
        <zip>166666</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2010</study_first_submitted>
  <study_first_submitted_qc>July 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2010</study_first_posted>
  <last_update_submitted>July 22, 2010</last_update_submitted>
  <last_update_submitted_qc>July 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2010</last_update_posted>
  <responsible_party>
    <organization>Ophthalmic Research Center</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Homatropine</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Mydriatics</mesh_term>
    <mesh_term>Chloramphenicol</mesh_term>
    <mesh_term>Chloramphenicol succinate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

